Surgeon and bioethicist Charles E. Binkley discusses the ethical implications and potential harms of using artificial intelligence (AI) in healthcare decision-making, particularly focusing on informed consent and physician responsibility. Dr. Binkley argues that patients should be informed when AI is used in their care, and that healthcare providers have a duty not only to inform patients of potential risks but also to mitigate those risks, emphasizing that the use of AI does not absolve physicians of their responsibilities to patients.
Surgeon and bioethicist Charles E. Binkley discusses the ethical implications of using artificial intelligence (AI) models in clinical decision-making, particularly focusing on patient informed consent. Dr. Binkley argues that patients should be fully informed about the use of AI in their healthcare, not only as patients but also as data donors and potential research subjects, to maintain autonomy, transparency, and trust in the physician-patient relationship.
Charles E. Binkley, director of bioethics at Santa Clara University’s Markkula Center for Applied Ethics, describes some critical ethical issues raised by the use of artificial intelligence (AI) and machine learning (ML) systems for clinical decision support in medicine. Dr. Binkley calls for resolution of these issues before these emerging technologies are widely implemented.
David S. Kemp, a professor at Berkeley Law, and Charles E. Binkley, MD, the director of bioethics at Santa Clara University’s Markkula Center for Applied Ethics, consider the implications of Pope Francis’s recently revealed statement endorsing same-sex civil unions as they pertain to a case currently before the U.S. Supreme Court. Kemp and Binkley argue that the Pope’s statement undermines the moral legitimacy of the Catholic organization’s position and casts a shadow on the premise of its legal arguments.
Surgeon and bioethicist Charles E. Binkley, MD, offers a perspective on how we might make sense of suffering, particularly in light of the present COVID-19 pandemic. Binkley suggests that through suffering, we are paradoxically able to find good, and in this instance, that good might be the practice of social reciprocity.
Clinical bioethicist Charles E. Binkley responds to a recent column by Verdict columnist and Cornell law professor Sherry F. Colb regarding the existence of evil in the world. Using a theological framework, Binkley addresses the central question Colb raised in her column and proposes a corollary question about communal evil.
Clinical bioethicist Charles E. Binkley and attorney David S. Kemp consider whether—and how—the Food and Drug Administration might reasonably regulate vaping devices, also known as electronic nicotine delivery system (ENDS), so that they can serve as an ethical alternative to combustible tobacco products. Specifically, Binkley and Kemp and call for further longitudinal data on the risks and benefits of ENDS and propose certain contingencies that must be in place before ENDS can serve as a viable replacement for conventional combustible tobacco products.
Charles E. Binkley, MD, FACS, co-chair of the Ethics Committee at Kaiser Permanente Medical Center in San Francisco, and attorney David Kemp conduct an ethical analysis of the American Health Care Act (AHCA), the proposed replacement for the Affordable Care Act, using the principles of impartiality and justice. Within this framework, Binkley and Kemp identify three values around which health care coverage should be prioritized, and they conclude that the AHCA fails to meet the ethical standards for government-supported health care.